11/11
10:02 am
cldx
Rating for CLDX
Medium
Report
Rating for CLDX
11/11
10:02 am
cldx
Rating for CLDX
Medium
Report
Rating for CLDX
10/21
08:42 am
cldx
Rating for CLDX
Low
Report
Rating for CLDX
10/21
08:42 am
cldx
Rating for CLDX
Low
Report
Rating for CLDX
10/21
08:03 am
cldx
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.
Low
Report
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.
10/21
08:03 am
cldx
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.
Low
Report
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $48.00 price target on the stock.
10/20
04:16 pm
cldx
Celldex initiated with an Outperform at Mizuho
Low
Report
Celldex initiated with an Outperform at Mizuho
10/20
04:16 pm
cldx
Celldex initiated with an Outperform at Mizuho
Low
Report
Celldex initiated with an Outperform at Mizuho
10/13
08:20 am
cldx
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $25.00 price target on the stock.
Low
Report
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $25.00 price target on the stock.
10/13
08:15 am
cldx
Rating for CLDX
Low
Report
Rating for CLDX
10/13
08:15 am
cldx
Rating for CLDX
Low
Report
Rating for CLDX
10/13
05:27 am
cldx
Celldex initiated with an Underweight at Barclays
Low
Report
Celldex initiated with an Underweight at Barclays
10/13
05:27 am
cldx
Celldex initiated with an Underweight at Barclays
Low
Report
Celldex initiated with an Underweight at Barclays
9/17
09:33 am
cldx
Rating for CLDX
Low
Report
Rating for CLDX